(Q37801912)

23 August 2017

Current approaches to the management of diabetic retinopathy and diabetic macular oedema (English)

1 reference

23 August 2017

1 reference

Francesco Boscia

1

1 reference

23 August 2017

1 November 2010

1 reference

23 August 2017

1 reference

23 August 2017

70

1 reference

23 August 2017

16

1 reference

23 August 2017

2171-2200

1 reference

https://scigraph.springernature.com/pub.10.2165/11538130-000000000-00000

23 August 2017

0 references

cites work

Comparison of time domain Stratus OCT and spectral domain SLO/OCT for assessment of macular thickness and volume

1 reference

https://api.crossref.org/works/10.2165%2F11538130-000000000-00000

Is neuronal dysfunction an early sign of diabetic retinopathy? Microperimetry and spectral domain optical coherence tomography (SD-OCT) study in individuals with diabetes, but no diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11538130-000000000-00000

Leukocyte-mediated endothelial cell injury and death in the diabetic retina

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11538130-000000000-00000

Microvascular lesions of diabetic retinopathy: clues towards understanding pathogenesis?

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11538130-000000000-00000

The polyol pathway as a mechanism for diabetic retinopathy: attractive, elusive, and resilient

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11538130-000000000-00000

Contributions of inflammatory processes to the development of the early stages of diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11538130-000000000-00000

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11538130-000000000-00000

Progressive Enlargement of Laser Scars Following Grid Laser Photocoagulation for Diffuse Diabetic Macular Edema

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11538130-000000000-00000

Clinical applications of the MicroPulse diode laser

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11538130-000000000-00000

Subthreshold diode micropulse panretinal photocoagulation for proliferative diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11538130-000000000-00000

Effects of conventional argon panretinal laser photocoagulation on retinal nerve fibre layer and driving visual fields in diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11538130-000000000-00000

Surgical management of the late complications of proliferative diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11538130-000000000-00000

Intravitreous injections of vascular endothelial growth factor produce retinal ischemia and microangiopathy in an adult primate

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11538130-000000000-00000

Glomerular-specific alterations of VEGF-A expression lead to distinct congenital and acquired renal diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11538130-000000000-00000

Polarized vascular endothelial growth factor secretion by human retinal pigment epithelium and localization of vascular endothelial growth factor receptors on the inner choriocapillaris. Evidence for a trophic paracrine relation

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11538130-000000000-00000

Intravitreal pegaptanib in severe proliferative diabetic retinopathy leading to the progression of tractional retinal detachment

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11538130-000000000-00000

Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy

21 January 2018

2 references

https://api.crossref.org/works/10.2165%2F11538130-000000000-00000

21 January 2018

12 December 2020

Effect of lisinopril on progression of retinopathy in normotensive people with type 1 diabetes. The EUCLID Study Group. EURODIAB Controlled Trial of Lisinopril in Insulin-Dependent Diabetes Mellitus

1 reference

12 December 2020

Pretreatment of posterior subtenon injection of triamcinolone acetonide has beneficial effects for grid pattern photocoagulation against diffuse diabetic macular oedema

1 reference

12 December 2020

Microperimetry and fundus autofluorescence in diabetic macular edema: subthreshold micropulse diode laser versus modified early treatment diabetic retinopathy study laser photocoagulation

1 reference

12 December 2020

Primary End Point (Six Months) Results of the Ranibizumab for Edema of the mAcula in diabetes (READ-2) study

1 reference

12 December 2020

Risk of adverse effects of intensified treatment in insulin-dependent diabetes mellitus: a meta-analysis

1 reference

12 December 2020

Intravitreal triamcinolone acetonide: a change in a paradigm

1 reference

12 December 2020

Hypoxic regulation of vascular endothelial growth factor in retinal cells

1 reference

12 December 2020

Effect of fenofibrate on the need for laser treatment for diabetic retinopathy (FIELD study): a randomised controlled trial.

1 reference

12 December 2020

Critical role of inducible nitric oxide synthase in degeneration of retinal capillaries in mice with streptozotocin-induced diabetes

1 reference

12 December 2020

Vascular endothelial growth factor-A is a survival factor for retinal neurons and a critical neuroprotectant during the adaptive response to ischemic injury.

1 reference

12 December 2020

Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders

1 reference

12 December 2020

Selective loss of inner retinal layer thickness in type 1 diabetic patients with minimal diabetic retinopathy

1 reference

12 December 2020

The prevalence of diabetic retinopathy among adults in the United States

1 reference

12 December 2020

Prolonged effect of intensive therapy on the risk of retinopathy complications in patients with type 1 diabetes mellitus: 10 years after the Diabetes Control and Complications Trial

1 reference

12 December 2020

Microincision vitrectomy surgery and intravitreal bevacizumab as a surgical adjunct to treat diabetic traction retinal detachment

1 reference

12 December 2020

Recruitment of marrow-derived endothelial cells to experimental choroidal neovascularization by local expression of vascular endothelial growth factor.

1 reference

12 December 2020

Neural apoptosis in the retina during experimental and human diabetes. Early onset and effect of insulin

1 reference

12 December 2020

Intravitreal bevacizumab for prevention of early postvitrectomy hemorrhage in diabetic patients: a randomized clinical trial

1 reference

12 December 2020

Endogenous VEGF is required for visual function: evidence for a survival role on müller cells and photoreceptors

1 reference

12 December 2020

Rapamycin inhibits VEGF-induced microvascular hyperpermeability in vivo

1 reference

12 December 2020

Intravitreal triamcinolone acetonide injection for treatment of refractory diabetic macular edema: a systematic review

1 reference

12 December 2020

Macular thickness measurements in healthy eyes using six different optical coherence tomography instruments

1 reference

12 December 2020

Upregulation of RAGE and its ligands in proliferative retinal disease

1 reference

12 December 2020

Surgery for diabetic retinopathy

1 reference

12 December 2020

DIABETIC RETINOPATHY AND RHEUMATOID ARTHRITIS

1 reference

12 December 2020

Regression of neovascular age-related macular degeneration following infliximab therapy

1 reference

12 December 2020

Randomized controlled study of an intravitreous dexamethasone drug delivery system in patients with persistent macular edema

1 reference

12 December 2020

Clinical review: The role of advanced glycation end products in progression and complications of diabetes

1 reference

12 December 2020

Retinal blood flow changes in patients with insulin-dependent diabetes mellitus and no diabetic retinopathy

1 reference

12 December 2020

VEGF-Trap: a VEGF blocker with potent antitumor effects

1 reference

12 December 2020

The renin-angiotensin system in retinal health and disease: Its influence on neurons, glia and the vasculature

1 reference

12 December 2020

Importance of pericytes and mechanisms of pericyte loss during diabetes retinopathy

1 reference

12 December 2020

Randomized controlled trial of an intravitreous dexamethasone drug delivery system in patients with diabetic macular edema.

1 reference

12 December 2020

Modulation of permeability and adhesion molecule expression by human choroidal endothelial cells.

1 reference

12 December 2020

Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy

1 reference

12 December 2020

Changes in the diabetic retinopathy epidemiology after 14 years in a population of Type 1 and 2 diabetic patients after the new diabetes mellitus diagnosis criteria and a more strict control of the patients

1 reference

12 December 2020

Intravitreal administration of the anti-tumor necrosis factor agent infliximab for neovascular age-related macular degeneration.

1 reference

12 December 2020

Comparison of combination posterior sub-tenon triamcinolone and modified grid laser treatment with intravitreal triamcinolone treatment in patients with diffuse diabetic macular edema

1 reference

12 December 2020

Comparison of clinical outcomes between 23-gauge and 20-gauge vitrectomy in patients with proliferative diabetic retinopathy

1 reference

12 December 2020

Role of steroids in the management of diabetic macular edema and proliferative diabetic retinopathy

1 reference

12 December 2020

Progression of tractional retinal detachment following intravitreal bevacizumab

1 reference

12 December 2020

Diabetic macular edema: a review of past, present, and future therapies

1 reference

12 December 2020

Risk factors associated with diabetic retinopathy in patients with diabetes mellitus type 2.

1 reference

12 December 2020

Comparison of photocoagulation with combined intravitreal triamcinolone for diabetic macular edema

1 reference

12 December 2020

Vascular permeability factor: a tumor-derived polypeptide that induces endothelial cell and monocyte procoagulant activity, and promotes monocyte migration

1 reference

12 December 2020

Intravitreal steroids for macular edema: the past, the present, and the future

1 reference

12 December 2020

Early detection of retinal thickness changes in diabetes using Optical Coherence Tomography.

1 reference

12 December 2020

Optical coherence tomographic patterns of diabetic macular edema.

1 reference

12 December 2020

Role of angiotensin II in retinal leukostasis in the diabetic rat.

1 reference

12 December 2020

A standardized method for reporting changes in macular thickening using optical coherence tomography

1 reference

12 December 2020

Peroxisome proliferator-activated receptor-alpha (PPARalpha): at the crossroads of obesity, diabetes and cardiovascular disease

1 reference

12 December 2020

Role of steroids in the treatment of diabetic macular edema

1 reference

12 December 2020

Prevention of leukostasis and vascular leakage in streptozotocin-induced diabetic retinopathy via intercellular adhesion molecule-1 inhibition

1 reference

12 December 2020

Combined laser and intravitreal triamcinolone for proliferative diabetic retinopathy and macular edema: one-year results of a randomized clinical trial

1 reference

12 December 2020

A central role for inflammation in the pathogenesis of diabetic retinopathy

1 reference

12 December 2020

Prevalence and healthcare costs of diabetic retinopathy: a population-based register study in Sweden

1 reference

12 December 2020

Bevacizumab pretreatment in vitrectomy with silicone oil for severe diabetic retinopathy.

1 reference

12 December 2020

Regression of sight-threatening macular edema in type 2 diabetes following treatment with the anti-tumor necrosis factor monoclonal antibody infliximab

1 reference

12 December 2020

Intravitreous dexamethasone effects on different patterns of diabetic macular edema.

1 reference

12 December 2020

Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus

1 reference

12 December 2020

Pegaptanib, a targeted anti-VEGF aptamer for ocular vascular disease

1 reference

12 December 2020

Spectral domain optical coherence tomography in diabetic macular edema

1 reference

12 December 2020

Selective activation of peroxisome proliferator-activated receptor (PPAR)alpha and PPAR gamma induces neoangiogenesis through a vascular endothelial growth factor-dependent mechanism.

1 reference

12 December 2020

Enzymatic vitreolysis.

1 reference

12 December 2020

Progressive enlargement of scattered photocoagulation scars in diabetic retinopathy

1 reference

12 December 2020

Intravitreal injection of bevacizumab and triamcinolone acetonide at the end of vitrectomy for diabetic vitreous hemorrhage: a comparative study

1 reference

12 December 2020

Blood pressure, lipids, and obesity are associated with retinopathy: the hoorn study

1 reference

12 December 2020

Ranibizumab versus verteporfin for neovascular age-related macular degeneration.

1 reference

12 December 2020

Purification and NH2-terminal amino acid sequence of guinea pig tumor-secreted vascular permeability factor.

1 reference

12 December 2020

A placebo-controlled trial of microplasmin intravitreous injection to facilitate posterior vitreous detachment before vitrectomy

1 reference

12 December 2020

Peroxisome proliferator-activated receptors and angiogenesis.

1 reference

12 December 2020

Decreased retinal ganglion cell layer thickness in patients with type 1 diabetes

1 reference

12 December 2020

1 reference

12 December 2020

Intravitreal bevacizumab versus combined bevacizumab-triamcinolone versus macular laser photocoagulation in diabetic macular edema.

1 reference

12 December 2020

Five-year results of a randomized trial with open-label extension of triamcinolone acetonide for refractory diabetic macular edema

1 reference

12 December 2020

Induction of nuclear factor-kappaB and its downstream genes by TNF-alpha and IL-1beta has a pro-apoptotic role in pancreatic beta cells

1 reference

12 December 2020

Dose of intravitreal bevacizumab (Avastin) used as preoperative adjunct therapy for proliferative diabetic retinopathy

1 reference

12 December 2020

Evaluation of a single intravitreal injection of dexamethasone phosphate in vitrectomy surgery for diabetic retinopathy complications

1 reference

12 December 2020

Effects of aggressive blood pressure control in normotensive type 2 diabetic patients on albuminuria, retinopathy and strokes

1 reference

12 December 2020

Intravitreal injection of pegaptanib sodium for proliferative diabetic retinopathy

1 reference

12 December 2020

Beneficial effects of intensive therapy of diabetes during adolescence: outcomes after the conclusion of the Diabetes Control and Complications Trial (DCCT).

1 reference

12 December 2020

Pars plana vitrectomy for diabetic fibrovascular proliferation with and without internal limiting membrane peeling

1 reference

12 December 2020

Pegaptanib 1-year systemic safety results from a safety-pharmacokinetic trial in patients with neovascular age-related macular degeneration

1 reference

12 December 2020

Increased microvascular permeability and endothelial fenestration induced by vascular endothelial growth factor

1 reference

12 December 2020

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

1 reference

12 December 2020

Preliminary report on effects of photocoagulation therapy. The Diabetic Retinopathy Study Research Group

1 reference

12 December 2020

Three-year follow-up of a randomized trial comparing focal/grid photocoagulation and intravitreal triamcinolone for diabetic macular edema

1 reference

12 December 2020

Visual side effects of successful scatter laser photocoagulation surgery for proliferative diabetic retinopathy: a literature review

1 reference

12 December 2020

Vitrectomy for diabetic macular oedema

1 reference

12 December 2020

Rapamycin reduces VEGF expression in retinal pigment epithelium (RPE) and inhibits RPE-induced sprouting angiogenesis in vitro

1 reference

12 December 2020

Angiotensin type 1 receptor blockers induce peroxisome proliferator-activated receptor-gamma activity

1 reference

12 December 2020

Optical coherence tomography imaging for diabetic retinopathy and macular edema

1 reference

12 December 2020

Effect of prior intensive therapy in type 1 diabetes on 10-year progression of retinopathy in the DCCT/EDIC: comparison of adults and adolescents

1 reference

12 December 2020

Infliximab for diabetic macular edema refractory to laser photocoagulation: a randomized, double-blind, placebo-controlled, crossover, 32-week study

1 reference

12 December 2020

Intravitreal triamcinolone versus laser photocoagulation for persistent diabetic macular oedema

1 reference

12 December 2020

Intravitreal steroids for macular edema in diabetes

1 reference

12 December 2020

Effects of intensive glucose lowering in type 2 diabetes

1 reference

12 December 2020

Short-term outcome of bimanual 23-gauge transconjunctival sutureless vitrectomy for patients with complicated vitreoretinopathies

1 reference

12 December 2020

The effect of long-term treatment with sulindac on the progression of diabetic retinopathy

1 reference

12 December 2020

Resource use and costs associated with diabetic macular edema in elderly persons

1 reference

12 December 2020

Immunological mechanisms in the pathogenesis of diabetic retinopathy

1 reference

12 December 2020

Determination of vitreous interleukin-1 (IL-1) and tumour necrosis factor (TNF) levels in proliferative diabetic retinopathy

1 reference

12 December 2020

Triamcinolone as adjunctive treatment to laser panretinal photocoagulation for proliferative diabetic retinopathy

1 reference

12 December 2020

Meta-analysis and review on the effect of bevacizumab in diabetic macular edema

1 reference

12 December 2020

Ranibizumab for neovascular age-related macular degeneration

1 reference

12 December 2020

Effect of blood pressure control on diabetic microvascular complications in patients with hypertension and type 2 diabetes

1 reference

12 December 2020

Blockade of angiotensin II attenuates VEGF-mediated blood-retinal barrier breakdown in diabetic retinopathy

1 reference

12 December 2020

Decreased contrast sensitivity in children and adolescents with type 1 diabetes mellitus

1 reference

12 December 2020

A Phase IIIb study to evaluate the safety of ranibizumab in subjects with neovascular age-related macular degeneration

1 reference

12 December 2020

Vascular endothelial growth factor-induced retinal permeability is mediated by protein kinase C in vivo and suppressed by an orally effective beta-isoform-selective inhibitor

1 reference

12 December 2020

Panretinal photocoagulation combined with intravitreal bevacizumab in high-risk proliferative diabetic retinopathy

1 reference

12 December 2020

Effects of blood pressure lowering and intensive glucose control on the incidence and progression of retinopathy in patients with type 2 diabetes mellitus: a randomised controlled trial.

1 reference

12 December 2020

Global data on visual impairment in the year 2002

1 reference

12 December 2020

Diabetic retinopathy: more than meets the eye.

1 reference

12 December 2020

Prospective randomised controlled trial comparing sub-threshold micropulse diode laser photocoagulation and conventional green laser for clinically significant diabetic macular oedema.

1 reference

12 December 2020

Burden of illness of diabetic macular edema: literature review

1 reference

12 December 2020

The prevalence of retinopathy in an unselected population of type 2 diabetes patients from Arhus County, Denmark

1 reference

12 December 2020

Vascular permeability in experimental diabetes is associated with reduced endothelial occludin content: vascular endothelial growth factor decreases occludin in retinal endothelial cells. Penn State Retina Research Group

1 reference

12 December 2020

Intravitreal bevacizumab in active progressive proliferative diabetic retinopathy

1 reference

12 December 2020

A phase II randomized double-masked trial of pegaptanib, an anti-vascular endothelial growth factor aptamer, for diabetic macular edema

1 reference

12 December 2020

Plasma levels of vascular endothelial growth factor and pigment epithelium-derived factor before and after intravitreal injection of bevacizumab

1 reference

12 December 2020

Intraoperative bleeding during vitrectomy for diabetic tractional retinal detachment with versus without preoperative intravitreal bevacizumab (IBeTra study).

1 reference

12 December 2020

Subthreshold micropulse diode laser photocoagulation for clinically significant diabetic macular oedema: a three-year follow up.

1 reference

12 December 2020

Optical coherence tomography in diabetic macular edema

1 reference

12 December 2020

Multifocal ERG defects associated with insufficient long-term glycemic control in adolescents with type 1 diabetes

1 reference

12 December 2020

Role of residual vitreous cortex removal in prevention of postoperative vitreous hemorrhage in diabetic vitrectomy

1 reference

12 December 2020

Transconjunctival sutureless vitrectomy for the treatment of vitreoretinal complications in patients with diabetes mellitus

1 reference

12 December 2020

PKC inhibition and diabetic microvascular complications

1 reference

12 December 2020

Use of pegaptanib for recurrent and non-clearing vitreous haemorrhage in proliferative diabetic retinopathy

1 reference

12 December 2020

Intravitreal triamcinolone and bevacizumab as adjunctive treatments to panretinal photocoagulation in diabetic retinopathy

1 reference

12 December 2020

Recent progress in research on beta-cell apoptosis by cytokines

1 reference

12 December 2020

VEGF164Is Proinflammatory in the Diabetic Retina

1 reference

12 December 2020

Ruboxistaurin: PKC-beta inhibition for complications of diabetes

1 reference

12 December 2020

Comparison of the modified Early Treatment Diabetic Retinopathy Study and mild macular grid laser photocoagulation strategies for diabetic macular edema

1 reference

12 December 2020

Changes in visual impairment prevalence by period of diagnosis of diabetes: the Wisconsin Epidemiologic Study of Diabetic Retinopathy

1 reference

12 December 2020

Vitrectomy in the management of diabetic eye disease

1 reference

12 December 2020

Early worsening of diabetic retinopathy in the Diabetes Control and Complications Trial

1 reference

12 December 2020

Development of ranibizumab, an anti-vascular endothelial growth factor antigen binding fragment, as therapy for neovascular age-related macular degeneration

1 reference

12 December 2020

Pretreatment with intravitreal triamcinolone before laser for diabetic macular edema: 6-month results of a randomized, placebo-controlled trial

1 reference

12 December 2020

Adolescents with Type 2 diabetes: early indications of focal retinal neuropathy, retinal thinning, and venular dilation

1 reference

12 December 2020

Experience with intravitreal bevacizumab as a preoperative adjunct in 23-G vitrectomy for advanced proliferative diabetic retinopathy

1 reference

12 December 2020

Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1

1 reference

12 December 2020

Pegaptanib for neovascular age-related macular degeneration

1 reference

12 December 2020

Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report number 1. Early Treatment Diabetic Retinopathy Study research group

1 reference

12 December 2020

Intravitreal bevacizumab for surgical treatment of severe proliferative diabetic retinopathy

1 reference

12 December 2020

Arterial thromboembolic events in patients with metastatic carcinoma treated with chemotherapy and bevacizumab

1 reference

12 December 2020

Intravitreal triamcinolone plus sequential grid laser versus triamcinolone or laser alone for treating diabetic macular edema: six-month outcomes.

1 reference

12 December 2020

A prospective trial of infliximab therapy for refractory uveitis: preliminary safety and efficacy outcomes.

1 reference

12 December 2020

Subthreshold diode micropulse photocoagulation for the treatment of clinically significant diabetic macular oedema

1 reference

12 December 2020

Effects of aspirin treatment on diabetic retinopathy. ETDRS report number 8. Early Treatment Diabetic Retinopathy Study Research Group

1 reference

12 December 2020

Rates of progression in diabetic retinopathy during different time periods: a systematic review and meta-analysis

1 reference

12 December 2020

Rapid reduction of hard exudates in eyes with diabetic retinopathy after intravitreal triamcinolone: data from a randomized, placebo-controlled, clinical trial

1 reference

12 December 2020

Intravitreal plasmin without associated vitrectomy as a treatment for refractory diabetic macular edema.

1 reference

12 December 2020

Comparing retinal thickness measurements from Cirrus spectral domain- and Stratus time domain-optical coherence tomography

1 reference

12 December 2020

Silent substitution S-cone electroretinogram in subjects with diabetes mellitus.

1 reference

12 December 2020

Vascular endothelial growth factor and diabetic retinopathy: pathophysiological mechanisms and treatment perspectives.

1 reference

12 December 2020

Effect of candesartan on progression and regression of retinopathy in type 2 diabetes (DIRECT-Protect 2): a randomised placebo-controlled trial

1 reference

12 December 2020

Inflammatory cytokines in vitreous fluid and serum of patients with diabetic vitreoretinopathy

1 reference

12 December 2020

The effect of glycaemic control on the quantitative characteristics of retinopathy lesions in patients with type 2 diabetes mellitus: 10-year follow-up study

1 reference

12 December 2020

1 reference

12 December 2020

Early vitrectomy for severe vitreous hemorrhage in diabetic retinopathy. Four-year results of a randomized trial: Diabetic Retinopathy Vitrectomy Study Report 5

1 reference

12 December 2020

Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes

1 reference

12 December 2020

Projection of diabetic retinopathy and other major eye diseases among people with diabetes mellitus: United States, 2005-2050.

1 reference

12 December 2020

The relation between bevacizumab injection and the formation of subretinal fibrosis in diabetic patients with panretinal photocoagulation

1 reference

12 December 2020

Adverse events after intravitreal infliximab (Remicade).

1 reference

12 December 2020

Insulin resistance in adipose tissue: direct and indirect effects of tumor necrosis factor-alpha

1 reference

12 December 2020

The North Jutland County Diabetic Retinopathy Study: population characteristics.

1 reference

12 December 2020

Modern-day clinical course of type 1 diabetes mellitus after 30 years' duration: the diabetes control and complications trial/epidemiology of diabetes interventions and complications and Pittsburgh epidemiology of diabetes complications experience (

1 reference

12 December 2020

A review of clinical trials of anti-VEGF agents for diabetic retinopathy

1 reference

12 December 2020

Inhibitors of ocular neovascularization: promises and potential problems.

1 reference

12 December 2020

Laser treatment of diabetic retinopathy

1 reference

12 December 2020

Ranibizumab for neovascular age-related macular degeneration

1 reference

12 December 2020

Renal and retinal effects of enalapril and losartan in type 1 diabetes

1 reference

12 December 2020

Exploratory analysis of diabetic retinopathy progression through 3 years in a randomized clinical trial that compares intravitreal triamcinolone acetonide with focal/grid photocoagulation

1 reference

12 December 2020

Tractional retinal detachment following intravitreal bevacizumab (Avastin) in patients with severe proliferative diabetic retinopathy

1 reference

12 December 2020

Intravitreal triamcinolone

1 reference

12 December 2020

Progression of retinopathy with intensive versus conventional treatment in the Diabetes Control and Complications Trial. Diabetes Control and Complications Trial Research Group

1 reference

12 December 2020

Diabetic vitrectomy: risks, prognosis, future trends

1 reference

12 December 2020

Emerging drugs for diabetic retinopathy

1 reference

12 December 2020

Intraocular sustained-release delivery systems for triamcinolone acetonide

1 reference

12 December 2020

Bevacizumab-augmented retinal laser photocoagulation in proliferative diabetic retinopathy: a randomized double-masked clinical trial

1 reference

12 December 2020

Effect of aspirin alone and aspirin plus dipyridamole in early diabetic retinopathy. A multicenter randomized controlled clinical trial. The DAMAD Study Group

1 reference

12 December 2020

Managing patients treated with bevacizumab combination therapy.

1 reference

12 December 2020

Panretinal photocoagulation versus PRP plus intravitreal bevacizumab for high-risk proliferative diabetic retinopathy (IBeHi study).

1 reference

12 December 2020

Topical mecamylamine for diabetic macular edema

1 reference

12 December 2020

Intravitreal triamcinolone acetonide for diabetic retinopathy

1 reference

12 December 2020

Prevalence of diabetic retinopathy in the United States, 2005-2008.

1 reference

12 December 2020

Suppression of Fas-FasL-induced endothelial cell apoptosis prevents diabetic blood-retinal barrier breakdown in a model of streptozotocin-induced diabetes

1 reference

12 December 2020

Single-session vs multiple-session pattern scanning laser panretinal photocoagulation in proliferative diabetic retinopathy: The Manchester Pascal Study

1 reference

12 December 2020

Vitreous traction and epiretinal membranes in diabetic macular oedema using spectral-domain optical coherence tomography

1 reference

12 December 2020

Vascular endothelial growth factor is a secreted angiogenic mitogen

1 reference

12 December 2020

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

1 reference

12 December 2020

Bevacizumab for neovascular ocular diseases

1 reference

12 December 2020

Management of diabetic retinopathy: a systematic review

1 reference

12 December 2020

Pathogenesis and classification of proliferative diabetic vitreoretinopathy.

1 reference

12 December 2020

Vascular endothelial growth factor and the potential therapeutic use of pegaptanib (macugen) in diabetic retinopathy

1 reference

12 December 2020

Sequential induction of angiogenic growth factors by TNF-alpha in choroidal endothelial cells

1 reference

12 December 2020

Diabetic macular edema: pathogenesis and treatment

1 reference

12 December 2020

A randomized trial comparing intravitreal triamcinolone acetonide and focal/grid photocoagulation for diabetic macular edema

1 reference

12 December 2020

Roles of endothelin-1 and selected proinflammatory cytokines in the pathogenesis of proliferative diabetic retinopathy: Analysis of vitreous samples

1 reference

12 December 2020

VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation

1 reference

12 December 2020

Intravitreal Bevacizumab (Avastin(®)) for Diabetic Retinopathy at 24-months: The 2008 Juan Verdaguer-Planas Lecture

1 reference

12 December 2020

The effect of ruboxistaurin on visual loss in patients with moderately severe to very severe nonproliferative diabetic retinopathy: initial results of the Protein Kinase C beta Inhibitor Diabetic Retinopathy Study (PKC-DRS) multicenter randomized cl

1 reference

12 December 2020

VEGF: once regarded as a specific angiogenic factor, now implicated in neuroprotection

1 reference

12 December 2020

Inhibition of preretinal and optic nerve head neovascularization in pigs by intravitreal triamcinolone acetonide

1 reference

12 December 2020

The Wisconsin Epidemiologic Study of Diabetic Retinopathy XXIII: the twenty-five-year incidence of macular edema in persons with type 1 diabetes

1 reference

12 December 2020

Is blockade of vascular endothelial growth factor beneficial for all types of diabetic retinopathy?

1 reference

12 December 2020

Intravitreous anti-VEGF for diabetic retinopathy: hopes and fears for a new therapeutic strategy

1 reference

12 December 2020

In vivo demonstration of increased leukocyte entrapment in retinal microcirculation of diabetic rats

1 reference

12 December 2020

Randomized trial of intravitreal bevacizumab alone or combined with triamcinolone versus macular photocoagulation in diabetic macular edema

1 reference

12 December 2020

Surgical and other treatments of diabetic macular edema: an update

1 reference

12 December 2020

Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity

1 reference

12 December 2020

Vitreous levels of vascular endothelial growth factor and stromal-derived factor 1 in patients with diabetic retinopathy and cystoid macular edema before and after intraocular injection of triamcinolone

1 reference

12 December 2020

Effects of medical therapies on retinopathy progression in type 2 diabetes

1 reference

12 December 2020

Patterns of diabetic macular edema with optical coherence tomography

1 reference

12 December 2020

Cerebrovascular accidents in ranibizumab

1 reference

12 December 2020

Pathologic features of vascular endothelial growth factor-induced retinopathy in the nonhuman primate

1 reference

12 December 2020

Update on systemic management of diabetes

1 reference

12 December 2020

Vascular endothelial growth factor and diabetic complications

1 reference

12 December 2020

Pathophysiology of diabetic macular edema

1 reference

12 December 2020

Effect of candesartan on prevention (DIRECT-Prevent 1) and progression (DIRECT-Protect 1) of retinopathy in type 1 diabetes: randomised, placebo-controlled trials

1 reference

12 December 2020

Long-term follow-up of vitrectomy for diffuse nontractional diabetic macular edema

1 reference

12 December 2020

Inhibition of diabetic leukostasis and blood-retinal barrier breakdown with a soluble form of a receptor for advanced glycation end products

1 reference

12 December 2020

Intravitreal injection of bevacizumab before vitrectomy for proliferative diabetic retinopathy.

1 reference

12 December 2020

Vascular endothelial growth factor reduced and connective tissue growth factor induced by triamcinolone in ARPE19 cells under oxidative stress.

1 reference

12 December 2020

Effect of ruboxistaurin on visual loss in patients with diabetic retinopathy

1 reference

12 December 2020

VEGF164-mediated inflammation is required for pathological, but not physiological, ischemia-induced retinal neovascularization.

1 reference

12 December 2020

Indications for photocoagulation treatment of diabetic retinopathy: Diabetic Retinopathy Study Report no. 14. The Diabetic Retinopathy Study Research Group

1 reference

12 December 2020

Visual electrophysiological responses in persons with type 1 diabetes

1 reference

12 December 2020

Intravitreal infliximab and choroidal neovascularization in an animal model

1 reference

12 December 2020

Extracellular carbonic anhydrase mediates hemorrhagic retinal and cerebral vascular permeability through prekallikrein activation

1 reference

12 December 2020

Pegaptanib sodium for neovascular age-related macular degeneration: third-year safety results of the VEGF Inhibition Study in Ocular Neovascularisation (VISION) trial

1 reference

12 December 2020

Angiotensin II type 1 receptor signaling contributes to synaptophysin degradation and neuronal dysfunction in the diabetic retina

1 reference

12 December 2020

Analysis of the effect of intravitreal bevacizumab injection on diabetic macular edema after cataract surgery

1 reference

12 December 2020

The Wisconsin Epidemiologic Study of Diabetic Retinopathy: XXII the twenty-five-year progression of retinopathy in persons with type 1 diabetes

1 reference

12 December 2020

Effect of ruboxistaurin in patients with diabetic macular edema: thirty-month results of the randomized PKC-DMES clinical trial

1 reference

12 December 2020

Vascular endothelial growth factor induces rapid phosphorylation of tight junction proteins occludin and zonula occluden 1. A potential mechanism for vascular permeability in diabetic retinopathy and tumors

1 reference

12 December 2020

The Wisconsin Epidemiologic Study of Diabetic Retinopathy. XV. The long-term incidence of macular edema

1 reference

12 December 2020

Novel potential mechanisms for diabetic macular edema: leveraging new investigational approaches

1 reference

12 December 2020

Vascular endothelial growth factor is a critical stimulus for diabetic macular edema

1 reference

12 December 2020

Sustained ocular delivery of fluocinolone acetonide by an intravitreal insert

1 reference

12 December 2020

Vitrectomy outcomes in eyes with diabetic macular edema and vitreomacular traction

1 reference

12 December 2020

VEGF activation of protein kinase C stimulates occludin phosphorylation and contributes to endothelial permeability.

1 reference

12 December 2020

Changes in retinal neovascularization after pegaptanib (Macugen) therapy in diabetic individuals

1 reference

12 December 2020

A pilot study of multiple intravitreal injections of ranibizumab in patients with center-involving clinically significant diabetic macular edema

1 reference

12 December 2020

Bevacizumab local complications

1 reference

12 December 2020

Update on laser treatment of diabetic macular edema

1 reference

12 December 2020

Suppression of diabetes-induced retinal inflammation by blocking the angiotensin II type 1 receptor or its downstream nuclear factor-kappaB pathway

1 reference

12 December 2020

Is blood pressure a predictor of the incidence or progression of diabetic retinopathy?

1 reference

12 December 2020

Early photocoagulation for diabetic retinopathy. ETDRS report number 9. Early Treatment Diabetic Retinopathy Study Research Group

1 reference

12 December 2020

Aspirin in diabetic retinopathy. A systematic review

1 reference

12 December 2020

Pathophysiology of diabetic macular edema

1 reference

12 December 2020

Intravitreal triamcinolone as an adjunct to standard laser therapy in coexisting high-risk proliferative diabetic retinopathy and clinically significant macular edema

1 reference

12 December 2020

An exploratory study of the safety, tolerability and bioactivity of a single intravitreal injection of vascular endothelial growth factor Trap-Eye in patients with diabetic macular oedema

1 reference

12 December 2020

Intravitreal triamcinolone for refractory diabetic macular edema: two-year results of a double-masked, placebo-controlled, randomized clinical trial

1 reference

12 December 2020

Fenofibrate regulates retinal endothelial cell survival through the AMPK signal transduction pathway

1 reference

12 December 2020

Randomised controlled trial of posterior sub-Tenon triamcinolone as adjunct to panretinal photocoagulation for treatment of diabetic retinopathy

1 reference

12 December 2020

Reduction in risk of progression of diabetic retinopathy

1 reference

12 December 2020

Pooled efficacy results from two multinational randomized controlled clinical trials of a single intravitreous injection of highly purified ovine hyaluronidase (Vitrase) for the management of vitreous hemorrhage.

1 reference

12 December 2020

Diabetes-enhanced tumor necrosis factor-alpha production promotes apoptosis and the loss of retinal microvascular cells in type 1 and type 2 models of diabetic retinopathy

1 reference

12 December 2020

Diabetic macular edema: what is focal and what is diffuse?

1 reference

12 December 2020

VEGF-dependent plasticity of fenestrated capillaries in the normal adult microvasculature

1 reference

12 December 2020

Subretinal fibrosis in diabetic macular edema. ETDRS report 23. Early Treatment Diabetic Retinopathy Study Research Group

1 reference

12 December 2020

Nonsteroidal anti-inflammatory drugs prevent early diabetic retinopathy via TNF-alpha suppression

1 reference

12 December 2020

Comparison of laser photocoagulation for diabetic retinopathy using 532-nm standard laser versus multispot pattern scan laser

1 reference

12 December 2020

Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema

1 reference

12 December 2020

Effect of trandolapril on regression of retinopathy in hypertensive patients with type 2 diabetes: a prespecified analysis of the benedict trial

1 reference

12 December 2020

Inhibition of TNF-alpha reduces laser-induced choroidal neovascularization

1 reference

12 December 2020

TNF-mediated inflammatory disease.

1 reference

12 December 2020

A prospective randomized trial of intravitreal bevacizumab or laser therapy in the management of diabetic macular edema (BOLT study) 12-month data: report 2.

1 reference

12 December 2020

Laser treatment in diabetic retinopathy

1 reference

12 December 2020

Small gauge, sutureless surgery techniques for diabetic vitrectomy

1 reference

12 December 2020

1 reference

12 December 2020

The North Jutland County Diabetic Retinopathy Study (NCDRS) 2. Non-ophthalmic parameters and clinically significant macular oedema.

1 reference

12 December 2020

10.2165/11538130-000000000-00000

Identifiers

DOI

1 reference

PubMed ID

20964459

Dimensions Publication ID

23 August 2017

0 references

1 reference

PubMed ID

20964459